FEVER OF UNKNOWN ORIGIN. Cristian Baicus Internal Medicine, Colentina Hospital

Similar documents
Diagnostic approach to fever of unknown origin. Steven Vanderschueren General Internal Medicine University Hospitals Leuven Belgium

NUCLEAR MEDICINE IMAGING IN FUO

ORIGINAL INVESTIGATION. From Prolonged Febrile Illness to Fever of Unknown Origin

CHAPTER 11 FEVER. Mr. Ashok Kumar Dept of Pharmacy Practice SRM College of Pharmacy SRM University

The Role of Invasive and Non-Invasive Procedures in Diagnosing Fever of Unknown Origin

Pathomechanism of fever. Fever of unknown origin. Fever and rash

DISCLOSURE. Relevant relationships with commercial entities none. Potential for conflicts of interest within this presentation none

Fever of Unknown Origin

Fever is one of the common presenting symptom in clinical practice. Most of the. Clinical profile of classical Fever of unknown origin (FUO)

Evaluation of Neck Mass. Disclosure. Learning Objectives 3/24/2014. Karen T. Pitman MD, FACS Banner MDACC, Gilbert AZ. Nothing to disclose

Lemuel Shattuck Hospital Consultation Service

Title:Giant cell arteritis exclusively detected by 18F-fluorodeoxyglucose positron emission tomography: a case report

Patient with Daily Headache NTERNATIONAL CLASSIFICATION HEADACHE DISORDERS. R. Allan Purdy, MD, FRCPC,FACP. Professor of Medicine (Neurology)

PDF hosted at the Radboud Repository of the Radboud University Nijmegen

Chapter 22. Pulmonary Infections

Clinical cases and pitfalls using FDG-PET. François Jamar Université Catholique de Louvain, Brussels, Belgium

Blau's Disease / Juvenile Sarcoidosis

Case 1. Background. Presenting Symptoms. Schecter Case1 Differential Diagnosis of TB 1

INVITED ARTICLES PYREXIA OF UNKNOWN ORIGIN - APPROACH TO MANAGEMENT

Diagnostic Value of EBUS-TBNA in Various Lung Diseases (Lymphoma, Tuberculosis, Sarcoidosis)

Atlas of the Vasculitic Syndromes

DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES

performed to help sway the clinician in what the appropriate diagnosis is, which can substantially alter the treatment of management.

Pelvic Inflammatory Disease (PID) Max Brinsmead PhD FRANZCOG July 2011

Evaluation of Infection/Inflammation: What is the Role of PET/CT?

Lung Cancer-a primer. Sai Yendamuri, MD Professor and Chair, Dept of Thoracic Surgery,RPCI,Buffalo

Polymyalgia rheumatica and giant cell arteritis

NEW CONCEPTS IN CROHN S DISEASE GLENDON BURRESS, MD PEDIATRIC GASTROENTEROLOGY ROCKFORD, IL

Laboratory Testing and Systemic Investigations in Uveitis

Clinical features and outcomes of patients with fever of unknown origin: a retrospective study

Fever of unknown origin in a Mediterranean survey from a division of internal medicine: report of 91 cases during a 12-year-period ( )

Fever. National Pediatric Nighttime Curriculum Written by Debbie Sakai, M.D. Institution: Lucile Packard Children s Hospital

unknown origin Summary Background [18F] FDG-PET/CT for the diagnosis of patients with fever of

Vasculitides in Surgical Neuropathology Practice

Diagnostic value of fluorine-18 fluorodeoxyglucose positron emission tomography / computed tomography in fever of unknown origin

Internal Medicine Certification Examination Blueprint

TB Intensive Houston, Texas

9/13/2015. Nothing to disclose

by author Diagnostics in fever of unknown origin an introduction

Leukocytosis - Some Learning Points

Recent trends in the distribution of causative diseases of fever of unknown origin

Lung Cancer - Suspected

Fever of Unknown Origin (FUO) Clinical Presentation. Author: Sandra G Gompf, MD, FACP, FIDSA; Chief Editor: Michael Stuart Bronze, MD

Rayos Prior Authorization Program Summary

DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES

Chapter 3. Neoplasms. Copyright 2015 Cengage Learning.

* MILIARY MOTTLING --

Proceedings of the World Small Animal Veterinary Association Sydney, Australia 2007

Upper Respiratory Tract Infections

PYELONEPHRITIS. Wendy Glaberson 11/8/13

Scintigraphic Findings and Serum Matrix Metalloproteinase 3 and Vascular Endothelial Growth Factor Levels in Patients with Polymyalgia Rheumatica

REFERRAL GUIDELINES: RHEUMATOLOGY

Overview INTRODUCTION 3/15/2018. Headache Emergencies. Other way to differentiate between them? Is there an easy way to differentiate between them?

Vasculitis and Vasculitides. OMONDI OYOO Physician/Rheumatologist; Senior Lecturer, Department of Medicine University of Nairobi

Antimicrobial Stewardship in Community Acquired Pneumonia

Using Big Data to Prevent Infections

Common things are common, but not always the answer

Tuberculosis otitis media

SEPTIC ARTHRITIS. Dr Ahmed Husam Al Ahmed Rheumatologist SYRIA. University of Science and technology Hospital Sanaa Yemen 18/Dec/2014

Diagnosis and Treatment of Respiratory Illness in Children and Adults

Fever is a common clinical problem. Diagnosis of its cause and management are both

Etiology and Resource Use of Fever of Unknown Origin in Hospitalized Children

An Update in the Management of Candidiasis

Rheumatologic Emergencies It s not just swollen joints. Joanne Homik Rheumatologist University of Alberta

In our paper, we suggest that tuberculosis and sarcoidosis are two ends of the same spectrum. Given the pathophysiological and clinical link between

The Lymphomas. An overview..

GIANT CELL ARTERITIS. Page 1 of 6 Reproduction of this material requires written permission of the Vasculitis Foundation. Copyright 2018.

Diagnostic Value of Common Inflammatory Markers on Fever of Unknown Origin

18F-FDG PET-CT IMAGING IN INFECTION AND INFLAMMATION

Key Points. Angus DC: Crit Care Med 29:1303, 2001

Vasculitis local: systemic

=ﻰﻤاﻤﺤﻠا ﺔﻴﻘﻠﺤﻠا ﺔذﺒاﻨﻠا

Issues regarding non-inferiority within the anti-bacterials area. Jon Armstrong, AstraZeneca Pharmaceuticals

APPROACH TO FEVER OF UNKNOWN ORIGIN IN CHILDREN

COUGH Dr. A m A it i e t sh A g A garwa w l Le L ctu t rer Departm t ent t o f f M e M dic i in i e

Infection Imaging In Nuclear Medicine: Arguing The Case for PET/CT.

Choosing an appropriate antimicrobial agent. 3) the spectrum of potential pathogens

Pulmonary Sarcoidosis - Radiological Evaluation

Relationships between Causes of Fever of Unknown Origin and Inflammatory Markers: A Multicenter Collaborative Retrospective Study

Chronic Hepatitis C. Risk Factors

The Naproxen Test as a Diagnostic Tool in the Causative Differentiation of Fever

Surgical indications: Non-malignant pulmonary diseases. Punnarerk Thongcharoen

Undifferentiated epithelioid sarcoma presenting as a fever of unknown origin: a case report

Vasculitis local: systemic

Inflammatory Bowel Diseases (IBD) Clinical aspects Nitsan Maharshak M.D., IBD Center, Department of Gastroenterology and Liver Diseases Tel Aviv Soura

Chapter 1: Certain Infectious and parasitic diseases (A00-B99)

Conjunctivitis in Cats

A Practical Approach to Leukopenia/Neutropenia in Children. Vandy Black, M.D., M.Sc., FAAP OLOL Children s Hospital August 24, 2014

: Undifferentiated Patient

Clostridium difficile Infection (CDI) Management Guideline

Lymphoma: What You Need to Know. Richard van der Jagt MD, FRCPC

PLEASE COMPLETE ALL SECTIONS OF THIS FORM

The X factor in a blue moon. Monique Lee Campbelltown Hospital

11/19/2012. The spectrum of pulmonary diseases in HIV-infected persons is broad.

Prefe f rred d t e t rm: : rhi h no n s o inu n s u iti t s

ACHA Clinical Benchmarking Program

Dr Rodney Itaki Lecturer Anatomical Pathology Discipline. University of Papua New Guinea School of Medicine & Health Sciences Division of Pathology

A Repeat Case of Idiopathic Spontaneous Hemothorax

PLEURAL EFFUSION. Prof. G. Zuliani

Transcription:

FEVER OF UNKNOWN ORIGIN Cristian Baicus Internal Medicine, Colentina Hospital www.baicus.ro

1961 definition 1. Ilness> 3 weeks 2. Fever>38.3 C (>101 F), on several occasions 3. Diagnosis uncertain after 1 week of study in hospital Petersdorf, Beeson. Medicine. 1961.

fièvre au long cours

Durack & Street Definition Classical FUO >3 weeks 38.3 C Diagnosis uncertain despite appropiate investig after 3 outpatient visits or 3 days in hospital Nosocomial FUO Neutropenic FUO HIV-associated FUO early empiric antimicrobial therapy Durack & Street, 1991

Definition of FUO today > 3 weeks 38.3 C, on several occasions No diagnosis after initial diagnostic investigation Exclusion of nosocomial fever and severe immunocompromise

Mourad et al. A Comprehensive Evidence-Based Approach to Fever of Unknown Origin. Arch Intern Med. 2003

FUO defies simplification. Reported causes exceed 200, and fall into diverse sub-speciality categories. There are no algorithms and few clues that reliably suggest or exclude particular diagnoses. The clinician must rely on very careful evaluation and detailed knowledge of a wide variety of diseases. Arnow, Flaherty. Lancet 1997.

Bottom line Thorough history taking and continuous observation is extremely important; repeat history after the physical if there are no clues. SORT C Exclude factitious fever and drug-related fever first. SORT C (little three) Infections (extrapulmonary tuberculosis most common) followed by neoplasms and multisystem disease are the most common causes of fever of unknown origin (FUO). SORT B (big three) In elderly patients, consider temporal arteritis and adult-onset Still's disease. SORT B Stevceva. Essential Evidence Plus, 2010.

49% of patients received a diagnosis infectious (16%) neoplasia (7%) noninfectious inflammatory disorders (22%) miscellaneous causes (4%) No cause of the fever was identified in 51% of the patients. Bleeker-Rovers, 2007.

Most common causes 14 disorders - 2/3 of the diagnoses 1. Infections: Endocarditis Tuberculosis Abdominal abscesses EBV/CMV infections 2. Malignancies: Lymphoma Leukemia 3. Non-infectious inflammatory disorders Adult-onset Still disease Systemic lupus erythematosus Polymyalgia rheumatica giant cell arteritis Sarcoidosis Crohn disease 4. Miscellaneous disorders Habitual hyperthermia Drug fever Subacute thyroiditis Vanderschueren. Arch Intern Med 2003;163:1033.

Diagnostic categories 1. Infections 2. Malignancies 3. Non-infectious inflammatory disorders a) Connective tissue diseases b) Vasculitides c) Granulomatous disorders 4. Miscellaneous disorders 5. Undiagnosed cases.

Most patients with FUO are not suffering from unusual diseases; instead they exhibit atypical manifestations of common illnesses. Petersdorf, Beeson. Medicine 1961

Diagnostic spectrum Depends on: Time Region Age Fever pattern (episodic vs continuous)

Time Mourad et al. Arch Intern Med. 2003

S.Vanderschueren. DIAGNOSTIC APPROACH TO FEVER OF UNKNOWN ORIGIN, 2009

Continuous/episodic Infection: continuous Systemic disease: continuous No diagnosis: episodic Knockaert, 1993 Probability not to reach a diagnosis: periodic, no anemia, normal protein electrophoresis de Kleijn, 1997

Infections As duration of fever increases, infectious etiology decreases Malignancy, factitious fevers and granulomatosis are more common in patients with prolonged FUO.

History Recent travel Exposure to pets and other animals Sexual history Work environment Contact with other people with similar symptoms Family history Past medical history list of medications Include OTC

Physical Exam Skin Mucous membranes Lymphadenopathy Organomegaly

Diagnosis A cost-effective individualized approach is essential in the evaluation of these patients to prevent performing inappropriate tests. Sutton s law: Look were the money is Potential diagnostic clues

Stevceva. Essential Evidence Plus, 2010

Mourad et al. Arch Intern Med. 2003

Diagnostic clues absent or misleading Total body inflammation tracer Wait and see Therapeutic trial

Selective tests Indicated in case of individual suspicion, to confirm the diagnosis (biopsy!, culture!); not as a routine ( fishing expedition ) Endoscopic techniques (e.g., GI, bronchoscopy) Selective radiographs (e.g., of teeth, sinuses, sacroiliac joints) Contrast studies (e.g., GI, arteriography) Invasive studies (mediastinoscopy, thoracoscopy, laparoscopy) Blind punctures (bone marrow, liver, lumbar puncture) Consider less invasive techniques (e.g., endobronchial US, echoendoscopy) Exception to the rule: temporal artery biopsy in 50+ Vandershueren, 2009

ESR>100 mm/h: LR+=19 for infection Fincher, Arch Intern Med 1986 Infection, 2 of 3: PCR>60mg/l Ferritin<500mcg/l, Eosinophils<40/mm3 Efsathiou, Eur J Int Med 2010

Therapeutic trials Therapeutic trails are seldom diagnostically rewarding and tend to obscure rather than to illuminate. Symptomatic: NSAID Therapeutic trial to be considered in case of deterioration Antibiotics: Broad spectrum antibiotics: stop if no defervescence after 3 days. Consider tetracyclines (or macrolides) Antituberculosis therapy: strongly consider in case of clinical deterioration. Corticosteroids: Do not start too early Consider adding antituberculosis therapy. Vandershueren, 2009

Prognosis Depend on underlying diagnosis Pts without diagnosis: good pronosis Knockaert, Arch Int Med 1996: 49 pts Spontaneous resolution during or shortly after hospitalisation: n=31 Continuous or recurrent fever (> 3m after discharge): n=18 cured : 10 (3 treated with corticosteroids) Persistent fevers: 8 Treated with corticosteroids (n=1) Treated with NSAIDs (n=6) Refused new investigation and died (n=1)

many patients are placed in the FUO category because the attending physicians overlook, disregard or reject an obvious clue. No malice is implied by this observation; it simply means that clinicians, being human instruments, are far from perfect. In order to mitigate the frequency and magnitude of these human errors, clinicians have to work that much harder. This means going over the patient again and again, repeating the history and physical examination, reviewing the chart, discussing the problem with colleagues in order to glean new ideas, and spending time in quiet contemplation of the clinical enigma. The approach to the patient with FUO is not to bring on yet another barrage of tests, some of which might be painful and all of which probably are expensive, nor to douse the patient with antimicrobials or to subject him to exploratory surgery, in the absence of clinical clues and only as a last resort. There is no substitute for observing the patient, talking to him and thinking about him. Larson EB et al. Medicine 1982; 61:269-292.

Conclusions FUO remains a challenge Keep in mind The diagnostic spectrum Local epidemiology Big three Little three Common causes are frequent. Go where the money is. When potentially diagnostic clues are absent or misleading, return to basics, wait and see and/or consider an inflammation tracer.